Our industry’s mandate is to supply high-quality medicines, make patient care affordable and help sustain Canada’s healthcare system. Cost-saving generic medicines are used to fill more than 70% of all the prescriptions dispensed each year in Canada. The complexity of the global supply chain impacts both the brand-name and generic pharmaceutical industries. The most common causes for drug shortages can be the quality and availability of active ingredients, or manufacturing issues, and regulatory issues.

CGPA and its member companies work with key stakeholders to mitigate disruptions in the supply and the impact on patients. Our member companies are also working with healthcare professionals and governments to identify the essential medicines that Canada needs to stockpile.